baltimoresun.com

« NIMBY sentiment keeps Md. electricity expensive | Main | Wall Street: Parental discretion strongly advised »

September 23, 2010

Sanity comes slowly, slowly to pharma regulation

From the NYT story on Avandia:

From now on, drug regulatory authorities are unlikely to approve medicines simply because they help diabetics control blood sugar levels — the standard for more than 80 years. Instead, authorities are likely to insist that companies prove that their medicines improve the quality or length of diabetics’ lives.

The Avandia story also marks a new and unsettling period for pharmaceutical companies because Avandia’s risks became known only after Dr. Nissen analyzed data from myriad trials that GlaxoSmithKline had been forced to post on its Web site as a result of a legal settlement. Such public postings are increasingly the norm, which means that drug makers can no longer easily hide or control scientific information about their medicines.

Posted by Jay Hancock at 4:09 PM | | Comments (1)
Categories: Health Care
        

Comments

This is the true picture of USA health care. Scams...kickbacks and fraud! The FDA has know this drug causes heart attacks for a long time. This is criminal! The drug maker GLAXO takes in 4.4 billion$$$$ every year and the FDA was not stopping this.

The drug makers run the FDA!

A filmmaker has been reversing diabetes in now 10 countries and the drug makers do not promote this

just google SPIRIT HAPPY DIET

Post a comment

All comments must be approved by the blog author. Please do not resubmit comments if they do not immediately appear. You are not required to use your full name when posting, but you should use a real e-mail address. Comments may be republished in print, but we will not publish your e-mail address. Our full Terms of Service are available here.

Verification (needed to reduce spam):

About Jay Hancock
Jay Hancock has been a financial columnist for The Baltimore Sun since 2001. He has also been The Baltimore Sun's diplomatic correspondent in Washington and its chief economics writer. Before moving to Baltimore in 1994 he worked for The Virginian-Pilot of Norfolk and The Daily Press of Newport News.

His columns appear Tuesdays and Sundays.
-- ADVERTISEMENT --

Most Recent Comments
Baltimore Sun coverage
Sign up for FREE business alerts
Get free Sun alerts sent to your mobile phone.*
Get free Baltimore Sun mobile alerts
Sign up for Business text alerts

Returning user? Update preferences.
Sign up for more Sun text alerts
*Standard message and data rates apply. Click here for Frequently Asked Questions.
Charm City Current
Stay connected